I agree that this site is using cookies. You can find further informations here.
X
Girolomoni, G.
321  results:
Search for persons X
?
1

Long‐term effectiveness and tolerability of apremilast in p..:

Gargiulo, L. ; Ibba, L. ; Malagoli, P....
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

P1019 "Totality-of-the-evidence" of proposed ustekinumab bi..:

Armuzzi, A ; Girolomoni, G ; Feldman, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1841-i1843 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Upadacitinib improves symptoms of concomitant allergic rhin..:

Gargiulo, L. ; Ibba, L. ; Piscazzi, F....
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

A risankizumab super responder profile identified by long‐t..:

Gargiulo, L. ; Ibba, L. ; Malagoli, P....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
5

Spesolimab in patients with flare of generalized pustular p..:

Bellinato, F. ; Gisondi, P. ; Dattola, A....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  5 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
6

First update of the living European guideline (EuroGuiDerm)..:

Wollenberg, A. ; Kinberger, M. ; Arents, B....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  11 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
7

European guideline (EuroGuiDerm) on atopic eczema: part I –..:

Wollenberg, A. ; Kinberger, M. ; Arents, B....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  9 - p. 1409-1431 , 2022
Link: https://doi.org/10.1111/..
 
?
8

European guideline (EuroGuiDerm) on atopic eczema – part II..:

Wollenberg, A. ; Kinberger, M. ; Arents, B....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  11 - p. 1904-1926 , 2022
Link: https://doi.org/10.1111/..
 
?
9

Monkeypox virus infection: what dermatologist needs to know:

Bellinato, F. ; Gisondi, P. ; Girolomoni, G.
Journal of the European Academy of Dermatology and Venereology.  , 2022
Link: https://doi.org/10.1111/..
 
?
10

Upadacitinib in patients with resistant atopic dermatitis: ..:

Dal Bello, G. ; Schena, D. ; Girolomoni, G.
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  9 - p. 1499-1500 , 2022
Link: https://doi.org/10.1111/..
 
?
11

Reduction of cutaneous advanced glycation end products leve..:

Maurelli, M. ; Bellinato, F. ; Gisondi, P..
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  8 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
12

Is risankizumab as needed administration a good option for ..:

Gisondi, P. ; Maurelli, M. ; Bellinato, F..
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  9 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
13

Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevan..:

Gisondi, P. ; Bellinato, F. ; Girolomoni, G.
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  2 - p. 165-166 , 2022
Link: https://doi.org/10.1111/..
 
?
14

Risk of non-alcoholic fatty liver disease in patients with ..:

Bellinato, F. ; Gisondi, P. ; Mantovani, A...
Journal of Endocrinological Investigation.  45 (2022)  7 - p. 1277-1288 , 2022
Link: https://doi.org/10.1007/..
 
?
15

The Combination of Dupilumab with Other Monoclonal Antibodi..:

Gisondi, P. ; Maurelli, M. ; Costanzo, A...
Dermatology and Therapy.  13 (2022)  1 - p. 7-12 , 2022
Link: https://doi.org/10.1007/..
 
1-15